HORNBACH Baumarkt Selects Blue Yonder To Accelerate Its Omni-Channel, Customer-Centric Strategy
19.9.2024 10:00:00 EEST | Business Wire | Press release
Today, retail offers a wide range of opportunities. Retailers must consistently focus on the needs of their customers if they want to be successful – even in the future. Tech innovation is accelerating. Consumers want to be free to decide whether they want to shop in the store or via smartphone or computer. Optimally, it should all be connected. Retailers are looking to innovate, add new services, and deliver experiences that consumers love, but they often face a costly and expensive fix because their tech stack was not built for modern experiences with efficiency in mind.
That’s why, as a pioneer in innovation and one of the leading DIY retailers in Europe, HORNBACH Baumarkt has selected Blue YonderInventory and Commits Services, part of Blue Yonder Order Management solutions.
HORNBACH Baumarkt is the largest and most important subsidiary of HORNBACH Holding. HORNBACH Baumarkt operates DIY megastores with garden centers and online stores in nine European countries. The DIY retail segment accounts for around 94% of consolidated sales for the company, with nearly half of these sales generated in Germany. Measured in terms of productivity, HORNBACH Baumarkt is the No. 1 DIY retailer in Germany by sales per square meter of sales area, based on the calculation principles of the BHB branch organization. In addition to its in-store business, the retailer has an online business, including click & collect, which accounts for around 13% of total sales. The DIY retailer offers an average of 50,000 items at its stationary stores and up to 290,000 items online.
Given the strong customer-first culture of the company and the strategic relevance of its online sales, HORNBACH Baumarkt decided to optimize the omni-channel order experience from search through purchase and delivery. By engaging customers with reliable information at the beginning of the shopping journey, HORNBACH Baumarkt will increase conversion and deliver more satisfying shopping experiences.
HORNBACH Baumarkt chose Blue Yonder because of its differentiated approach to optimizing omni-channel operations, the deep understanding of the order process, and the unique vision and strategy for the future of the supply chain.
Blue Yonder Inventory and Commits Services will allow HORNBACH Baumarkt to:
- Empower customers with options, knowledge and choice, delivering a consistent and frictionless experience, thereby improving customer satisfaction.
- Provide accurate, real-time, network-wide inventory visibility and availability across all channels.
- Optimize order fulfillment, taking into accounts costs, capacity, time, and other business parameters.
- Drive rapid innovation for customer-facing services, while modernizing the tech stack.
“As part of our Interconnected Retail strategy, we prioritize customer satisfaction and continuously evaluate our processes to enhance the customer experience,” said Nils Hornbach, member, Management Board, HORNBACH Baumarkt AG. “Our internal assessment revealed the need for a further development to improve order management across channels and provide a seamless omni-channel purchasing journey. After a thorough vendor evaluation, we selected Blue Yonder for their specialized expertise and market-leading order decisioning capabilities. Their architecture and technology ensure rapid time-to-value, scalability and performance, making Blue Yonder our preferred choice to support our digital transformation journey. This will give us an advantage in inventory availability and fulfillment, that will create high value for our customers. We look forward to collaborating with the Blue Yonder team.”
Blue Yonder’s flexible microservices-based solutions approach, embedded with machine learning (ML) and artificial intelligence (AI), will help HORNBACH Baumarkt to optimize the entire omni-channel customer journey, starting with an engaging customer experience through efficient order fulfillment. The retailer will also be able to accelerate its in-store and digital business to gain an advantage through a model that supports rapid implementation.
“HORNBACH Baumarkt is leading a game-changing transformation, focused on customer centricity and we are proud to welcome them among our customers,” said Gael Ramaen, vice president, EMEA Retail, Blue Yonder. “Blue Yonder Order Management solutions are engineered to scale, perform and operate under the highest volumes seen on the market. It can transform order management with an augmentative, composable approach, which delivers rapid time-to-market. We cannot wait to support HORNBACH Baumarkt in speeding their ongoing digital transformation.”
Additional Resources:
- Solution Sheet: Inventory Availability and Order Optimization
- E-book: Microservices: Your Next Big Move Just Got Smaller
- Learn more about Blue Yonder Order Management microservices
About HORNBACH Holding
HORNBACH is an independent, family-run, and publicly listed major company that generated net revenue of 6.2 billion euros in the 2023/24 fiscal year (balance sheet date: 29 February 2024). This makes the HORNBACH group one of the five largest home improvement and garden retailers in Europe. Founded in 1877, HORNBACH is the only company in the home improvement industry with a history spanning six generations. The company currently operates 169 home and garden centers, two specialist stores, and online shops in nine European countries. The sales concept and product range are particularly geared to the needs of project customers and professionals. HORNBACH guarantees its customers permanently low prices, making it the price leader in the industry. The company’s high quality of advice and excellent service have been recognized in numerous independent tests and studies. With pioneering achievements such as the first combined home and garden center (1968), the first megastore (1980), and the first home center with a drive-in facility (2003), HORNBACH is continually at the forefront of innovation. For decades, HORNBACH has been regarded as a job creator, with more than 25,000 employees now contributing to the company’s success. HORNBACH Holding
About Blue Yonder
Blue Yonder is the world leader in digital supply chain transformation. Retailers, manufacturers and logistics service providers worldwide rely on Blue Yonder to optimize and accelerate their supply chain from planning through fulfillment, delivery, and returns. Blue Yonder’s AI-driven supply chain platform and multi-enterprise, multi-tier network enable more accurate forecasting and dynamic management of capacity, inventory and transport. Blue Yonder helps businesses navigate modern supply chain complexity and volatility with more resilient, sustainable supply chains to delight customers, scale profitably, and run flawlessly. www.blueyonder.com
“Blue Yonder” is a trademark or registered trademark of Blue Yonder Group, Inc. Any trade, product or service name referenced in this document using the name “Blue Yonder” is a trademark and/or property of Blue Yonder Group, Inc. All other company and product names may be trademarks, registered trademarks or service marks of the companies with which they are associated.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240919416372/en/
Contacts
Blue Yonder Corporate Communications:
mediarelationsteam@blueyonder.com
U.S.: +1 480-308-3037
EMEA: +39 335 7849149
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom